Name: UMIN ID:
Unique ID issued by UMIN | UMIN000034499 |
---|---|
Receipt number | R000039334 |
Scientific Title | Investigation of efficacy of nivolumab in patients with recurrent and refractory peripheral T cell lymphoma: Investigator initiated phase 2 clinical trial. |
Date of disclosure of the study information | 2018/10/15 |
Last modified on | 2022/10/18 10:24:21 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/10/15 12:58:24 | ||
2 | Update | 2019/04/16 09:13:32 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
3 | Update | 2019/04/16 09:16:59 | Recruitment status Date of IRB Last follow-up date |
|
4 | Update | 2021/11/11 09:43:25 | Recruitment status Last follow-up date |
|
5 | Update | 2021/11/11 09:46:25 | Number of participants that the trial has enrolled |
|
6 | Update | 2022/10/18 10:22:31 | Key inclusion criteria Key inclusion criteria |
|
7 | Update | 2022/10/18 10:24:21 | Last follow-up date |